Beyond IL-5 inhibition for the treatment of episodic angioedema with eosinophilia (Gleich syndrome).

Autor: Ledoult E; Service de médecine interne et d'immunologie clinique, Centre de Référence des Syndromes Hyperéosinophiliques (CEREO), CHU Lille, Lille, France; Université de Lille, INSERM U1286 INFINITE - Institute for Translational Research in Inflammation, Lille, France. Electronic address: emmanuel.ledoult2@chu-lille.fr., Groh M; Université de Lille, INSERM U1286 INFINITE - Institute for Translational Research in Inflammation, Lille, France; Service de médecine interne, Centre de Référence des Syndromes Hyperéosinophiliques (CEREO), Hôpital Foch, Suresnes, France., Kahn JE; Service de médecine interne, Centre de Référence des Syndromes Hyperéosinophiliques (CEREO), Hôpital Foch, Suresnes, France; Université Paris Saclay, Service de médecine interne, Hôpital Ambroise Paré, Assistance Publique Hôpitaux de Paris, Boulogne Billancourt, France., Lefevre G; Service de médecine interne et d'immunologie clinique, Centre de Référence des Syndromes Hyperéosinophiliques (CEREO), CHU Lille, Lille, France; Université de Lille, INSERM U1286 INFINITE - Institute for Translational Research in Inflammation, Lille, France; Laboratoire d'immunologie, CHU Lille, Lille, France.
Jazyk: angličtina
Zdroj: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2024 Nov; Vol. 154 (5), pp. 1339-1340. Date of Electronic Publication: 2024 Sep 21.
DOI: 10.1016/j.jaci.2024.04.033
Abstrakt: Competing Interests: Disclosure statement Disclosure of potential conflict of interest: E. Ledoult reports personal fees for meetings from AstraZeneca and GSK. M. Groh reports consulting fees and personal fees for advisory boards or meetings from AstraZeneca and GSK. J.-E. Kahn reports consulting fees and personal fees for advisory boards or meetings from AstraZeneca and GSK. G. Lefevre reports consulting fees, personal fees for advisory boards or meetings, and research fundings from AstraZeneca and GSK.
Databáze: MEDLINE
Externí odkaz: